Business
LifeTech Scientific Corporation Announces 2025 Annual Results: Steady Revenue Growth with Adjusted Net Profit Increasing 24.9%
LifeTech Scientific Corporation ("LifeTech" or the "Company", together with its subsidiaries, the "Group"; stock code: 1302.HK), a leading medical device company specializing in minimally invasive interventional solutions for cardio-cerebrovascular and peripheral vascular diseases, today announced its audited consolidated results for the year ended 31 December 2025 (the "Reporting Period").
About this update from Lifetech Scientific Corporation
[{"type":"text","content":"SHENZHEN, China, March 31, 2026 /PRNewswire/ -- LifeTech Scientific Corporation ("LifeTech" or the "Company", together with its subsidiaries, the "Group"; stock code: 1302.HK), a leading medical device company specializing in minimally invasive interventional solutions for cardio-cerebrovascular and peripheral vascular diseases, today announced its audited consolidated results for the year ended 31 December 2025 (the "Reporting Period").","length":481,"tagName":"p"},{"type":"image","alt":"(PRNewsfoto/先健科技公司)","displaySize":"","headline":null,"caption":"(PRNewsfoto/先健科技公司)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":112,"url":"https://media.zenfs.com/en/prnewswire.com/0e2198d0d2717c2fc73af93eded26f9b"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/9C0TAZCZeEXLgyRKNqbhXQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTE5Nw--/https://media.zenfs.com/en/prnewswire.com/0e2198d0d2717c2fc73af93eded26f9b","width":400,"height":112}},"href":"https://mma.prnewswire.com/media/1744133/Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"list","items":[{"val":[{"type":"text","content":"Steady Revenue GrowthThe Group recorded revenue of approximately RMB1,369.8 million, representing a year-on-year increase of approximately 5.1% during the Reporting Period. The growth was primarily driven by strong sales of stent grafts, which increased by approximately 19.9% year-on-year.","length":291,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":291,"olType":false},{"type":"list","items":[{"val":[{"type":"text","content":"Solid ProfitabilityGross profit of the Group amounted to approximately RMB1,019.1 million during the Reporting Period, representing a year-on-year growth of approximately 3.8%. The gross profit margin was approximately 74.4%. Excluding certain non-recurring items[1], the net profit of the Company reached approximately RMB353.4 million during the Reporting Period, representing a significant increase of approximately 24.9% year-on-year.","length":439,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":439,"olType":false},{"type":"list","items":[{"val":[{"type":"text","content":"Strong Cash Position:As at 31 December 2025, the Group's cash and cash equivalents were approximately RMB...